{"id":"beta-blocker","safety":{"commonSideEffects":[{"rate":"10-20","effect":"Fatigue"},{"rate":"5-15","effect":"Bradycardia"},{"rate":"5-10","effect":"Hypotension"},{"rate":"5-10","effect":"Dizziness"},{"rate":"5-10","effect":"Erectile dysfunction"},{"rate":"1-5","effect":"Bronchospasm (non-selective agents)"},{"rate":"variable","effect":"Hyperglycemia or masked hypoglycemia symptoms"}]},"_chembl":{"chemblId":"CHEMBL1402326","moleculeType":"Small molecule","molecularWeight":"540.13"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Beta blockers competitively antagonize beta-1 and/or beta-2 adrenergic receptors, decreasing cardiac contractility, heart rate, and renin release. This leads to reduced myocardial oxygen demand and lower blood pressure, making them effective for managing hypertension, angina, and arrhythmias. Different beta blockers have varying selectivity for beta-1 versus beta-2 receptors and additional properties such as intrinsic sympathomimetic activity or vasodilatory effects.","oneSentence":"Beta blockers reduce heart rate and blood pressure by blocking the effects of adrenaline on beta-adrenergic receptors in the heart and blood vessels.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:20:45.964Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"},{"name":"Angina pectoris"},{"name":"Arrhythmias (including atrial fibrillation)"},{"name":"Heart failure"},{"name":"Post-myocardial infarction"},{"name":"Migraine prophylaxis"}]},"trialDetails":[{"nctId":"NCT07045038","phase":"NA","title":"Blood Flow Restricted Resistance Exercises Versus Low Level Laser on Cardiac Functions in Patients With Chronic Heart Failure","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cairo University","startDate":"2025-01-20","conditions":"Heart Failure NYHA Class II","enrollment":60},{"nctId":"NCT06724653","phase":"NA","title":"Tapering Heart Failure Medication in Patients With Heart Failure With Recovered Ejection Fraction; Open Label Prospective Random Trial","status":"RECRUITING","sponsor":"Chungnam National University Hospital","startDate":"2025-03-06","conditions":"Heart Failure, Ejection Fraction, Recovery of Function","enrollment":150},{"nctId":"NCT07493603","phase":"PHASE1, PHASE2","title":"A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease","status":"RECRUITING","sponsor":"Xia Liang","startDate":"2026-01-16","conditions":"Coronary Heart Disease, Coronary Artery Disease, Atheroscleroses","enrollment":30},{"nctId":"NCT07489352","phase":"NA","title":"N-of-1 Trial to Promote Beta-Blocker Titration in Heart Failure","status":"NOT_YET_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2026-05-05","conditions":"Heart Failure, Beta-blocker, Older Adults","enrollment":50},{"nctId":"NCT07490067","phase":"PHASE4","title":"Mechanistic Clinical Trial Comparing the Pharmacokinetics/Pharmacodynamics of Metoprolol in Heart Failure With Reduced Ejection Fraction Patients With Low vs. High Polygenic Score","status":"NOT_YET_RECRUITING","sponsor":"University of Michigan","startDate":"2026-04","conditions":"Heart Failure With Reduced Ejection Fraction","enrollment":100},{"nctId":"NCT07483151","phase":"","title":"Venous Congestion And Cognitive Dysfunction After Cardiac Surgery","status":"RECRUITING","sponsor":"Zhuan Zhang","startDate":"2024-11-01","conditions":"Intraoperative Venous Congestion And Cognitive Dysfunction After Cardiac Surgery","enrollment":110},{"nctId":"NCT05081999","phase":"PHASE4","title":"De-Adoption of Beta-Blockers in Patients With Stable Ischemic Heart Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Alberta","startDate":"2023-01-30","conditions":"Stable Ischemic Heart Disease, Coronary Artery Disease, Beta-blocker Therapy","enrollment":59},{"nctId":"NCT05524077","phase":"NA","title":"Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Western Sydney Local Health District","startDate":"2020-07-08","conditions":"Heart Disease Structural Disorder, Ventricular Tachycardia, Cardiomyopathy, Dilated","enrollment":162},{"nctId":"NCT05479123","phase":"PHASE4","title":"Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas","status":"TERMINATED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2022-06-23","conditions":"Infantile Hemangioma","enrollment":52},{"nctId":"NCT02627196","phase":"NA","title":"Baroreflex Activation Therapy for Heart Failure","status":"COMPLETED","sponsor":"CVRx, Inc.","startDate":"2016-04-19","conditions":"Heart Failure","enrollment":1090},{"nctId":"NCT06566794","phase":"NA","title":"KF2022#4-trial: Effects of a Beta Blocker and NSAID on CYP Mediated Drug Metabolism","status":"COMPLETED","sponsor":"Helsinki University Central Hospital","startDate":"2024-08-22","conditions":"Drug Interaction","enrollment":12},{"nctId":"NCT04412096","phase":"PHASE4","title":"Aqueous Humor Dynamic Components That Determine Intraocular Pressure Variance","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2020-11-23","conditions":"Glaucoma, OHT - Ocular Hypertension","enrollment":59},{"nctId":"NCT07445581","phase":"NA","title":"Tanhuo Decoction for Acute Coronary Syndrome With Cerebral Atherosclerosis in Elderly Patients","status":"NOT_YET_RECRUITING","sponsor":"Jinggang Xia, MD","startDate":"2026-02-28","conditions":"Acute Coronary Syndrome Comorbid With Cerebral Atherosclerosis","enrollment":480},{"nctId":"NCT07447297","phase":"NA","title":"Efficacy of Early Rhythm Control Therapy in Patients With Subclinical Atrial Fibrillation","status":"RECRUITING","sponsor":"Samsung Medical Center","startDate":"2024-01-02","conditions":"Atrial Fibrillation (AF), Diseases of the Circulatory System, Atrial Flutter","enrollment":520},{"nctId":"NCT07445334","phase":"NA","title":"Catheter Ablation Versus Anti-arrhythmic Drugs for Premature Ventricular Complexes","status":"NOT_YET_RECRUITING","sponsor":"Western Sydney Local Health District","startDate":"2026-03-01","conditions":"Premature Ventricular Complexes, Premature Ventricular Contraction (PVC), Premature Ventricular Beats","enrollment":40},{"nctId":"NCT07298993","phase":"PHASE4","title":"Deprescribing Beta-Blockers in Elders With Heart Failure With Preserved Ejection Fraction (DEPRESCRIBE-HFpEF)","status":"ENROLLING_BY_INVITATION","sponsor":"Weill Medical College of Cornell University","startDate":"2026-02-02","conditions":"Heart Failure, HFpEF, HFpEF - Heart Failure With Preserved Ejection Fraction","enrollment":240},{"nctId":"NCT07167368","phase":"NA","title":"Exercise Rehabilitation for Cardiorenal Syndrome in HFrEF Patients","status":"RECRUITING","sponsor":"Haiyan Pan","startDate":"2025-09-15","conditions":"Cardiorenal Syndrome","enrollment":60},{"nctId":"NCT06764966","phase":"PHASE2","title":"Statin and Beta Blocker Use in Patients With Decompensated Cirrhosis","status":"RECRUITING","sponsor":"CAMC Health System","startDate":"2025-09-09","conditions":"Decompensated Liver Cirrhosis, Cirrhosis, Decompensated Cirrhosis of Liver","enrollment":50},{"nctId":"NCT07252310","phase":"PHASE4","title":"Pilot Study of StudyU for N-of-1 Trials in HFrEF Patients (N-of-1 App)","status":"ENROLLING_BY_INVITATION","sponsor":"Weill Medical College of Cornell University","startDate":"2026-02-10","conditions":"HFrEF - Heart Failure With Reduced Ejection Fraction, Heart Failure, Heart Failure, Systolic","enrollment":5},{"nctId":"NCT07044700","phase":"","title":"Real-world Comparative Effectiveness and Safety of Jardiance in Chinese Patients With Heart Failure of Reduced Ejection Fraction","status":"NOT_YET_RECRUITING","sponsor":"Boehringer Ingelheim","startDate":"2028-01-31","conditions":"Heart Failure of Reduced Ejection Fraction (HFrEF)","enrollment":5000},{"nctId":"NCT07272902","phase":"NA","title":"Treating Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Ablation or Medication","status":"RECRUITING","sponsor":"Nova Scotia Health Authority","startDate":"2026-01-01","conditions":"Atrial Fibrillation (AF), Heart Failure With Mildly Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction (HFPEF)","enrollment":84},{"nctId":"NCT06526195","phase":"NA","title":"Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure","status":"RECRUITING","sponsor":"Abbott Medical Devices","startDate":"2024-12-13","conditions":"Heart Failure, Heart Diseases, Cardiovascular Diseases","enrollment":850},{"nctId":"NCT07293910","phase":"PHASE2","title":"Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection","status":"RECRUITING","sponsor":"Tanta University","startDate":"2026-02-15","conditions":"HELICOBACTER PYLORI INFECTIONS, Helicobacter Infection, Helicobacter Pylori Gastrointestinal Tract Infection","enrollment":66},{"nctId":"NCT07405229","phase":"PHASE4","title":"MEdical Treatment in Idiopathic Ventricular Fibrillation Patients","status":"RECRUITING","sponsor":"Bo Gregers Winkel","startDate":"2018-05-01","conditions":"Idiopathic Ventricular Fibrillation, Cardiac Arrest, Out-Of-Hospital","enrollment":218},{"nctId":"NCT07099677","phase":"NA","title":"Short-Term Effects of Antihypertensive Drugs on Postural Balance and Fall Risk","status":"RECRUITING","sponsor":"Abant Izzet Baysal University","startDate":"2025-08-01","conditions":"Hypertension, Fall Risk, Postural Balance","enrollment":186},{"nctId":"NCT07405671","phase":"PHASE4","title":"Flecainide Safety in Patients With Coronary Artery Disease and Atrial Fibrillation","status":"NOT_YET_RECRUITING","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2026-09","conditions":"Atrial Fibrillation (AF), Coronary Artery Disease","enrollment":988},{"nctId":"NCT07405944","phase":"PHASE4","title":"Vericiguat and Reverse Remodeling Indices in Heart Failure","status":"RECRUITING","sponsor":"University Medical Centre Ljubljana","startDate":"2025-11-01","conditions":"Heart Failure With Reduced Ejection Fraction (HFrEF), Chronic Heart Failure","enrollment":60},{"nctId":"NCT04239144","phase":"NA","title":"Sympathetic Denervation by Video-assisted Thoracoscopy in Control of Cardiac Arrhythmias in Patients With Chagas Disease","status":"COMPLETED","sponsor":"University of Sao Paulo General Hospital","startDate":"2018-11-09","conditions":"Chagas Cardiomyopathy, Ventricular Arrythmia","enrollment":45},{"nctId":"NCT05734690","phase":"PHASE4","title":"COPILOT-HF: Cooperative Program for ImpLementation of Optimal Therapy in Heart Failure","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2023-05-05","conditions":"Heart Failure","enrollment":503},{"nctId":"NCT06299514","phase":"NA","title":"RAFT - Pace &Ablate","status":"RECRUITING","sponsor":"Habib Khan","startDate":"2024-04-25","conditions":"Atrial Fibrillation, Heart Failure, Pacemaker","enrollment":600},{"nctId":"NCT04434664","phase":"PHASE4","title":"BLOCKade of Calcium Channels and Beta Adrenergic Receptors for the Treatment of Hypertension in HFpEF","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2021-12-01","conditions":"Heart Failure With Preserved Ejection Fraction, Hypertension","enrollment":50},{"nctId":"NCT03138603","phase":"PHASE3","title":"Metoprolol to Reduce Perioperative Myocardial Injury","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2016-12","conditions":"Heart Diseases","enrollment":72},{"nctId":"NCT07303556","phase":"NA","title":"Improving Cardiovascular Disease Diagnosis and Treatment in Kazakhstan Using Metabolic Correction With GLP-1 Drugs","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nazarbayev University","startDate":"2024-12-18","conditions":"Heart Failure, Diabete Type 2, Arterial Hypertension","enrollment":120},{"nctId":"NCT04849806","phase":"","title":"Sympathetic Nerve Activity Predictors in Patients With Chronic Obstructive Pulmonary Disease","status":"RECRUITING","sponsor":"RWTH Aachen University","startDate":"2022-05-10","conditions":"COPD, Sympathetic Nervous System Diseases, Catecholamine; Overproduction","enrollment":135},{"nctId":"NCT07362966","phase":"PHASE4","title":"Effect of Colchicine on Progression of Coronary Atherosclerosis in Patients With TET2-CHIP Variant","status":"NOT_YET_RECRUITING","sponsor":"Shenyang Northern Hospital","startDate":"2026-02-24","conditions":"Colchicine, Coronary Atherosclerosis Management, Clonal Hematopoiesis of Indeterminate Potential","enrollment":120},{"nctId":"NCT07355023","phase":"NA","title":"AI-Enabled Electrocardiogram-Guided Guideline-Directed Medical Therapy on Incident Left Ventricular Dysfunction: A Target Trial Emulation Study","status":"RECRUITING","sponsor":"Tri-Service General Hospital","startDate":"2026-01-01","conditions":"Left Ventricular (LV) Systolic Dysfunction","enrollment":5000},{"nctId":"NCT07349979","phase":"NA","title":"PCI With Guideline-Directed Medical Therapy for HFpEF Patients With Ischemic Cardiomyopathy","status":"NOT_YET_RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2026-01-30","conditions":"Heart Failure With Reduced Ejection Fraction, Coronary Artery Disease","enrollment":654},{"nctId":"NCT07103655","phase":"PHASE4","title":"The Therapeutic Value of Mavacamten in Hypertrophic Cardiomyopathy With Mid-to-Apical Left Ventricular Obstruction","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2026-01-01","conditions":"Hypertrophic Cardiomyopathy (HCM)","enrollment":132},{"nctId":"NCT06518694","phase":"PHASE3","title":"Beta-blOckers discoNtinuation in Patients Presenting Heart FaIlure With REcovered Left Ventricular Ejection Fraction","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-02-11","conditions":"Heart Failure","enrollment":1300},{"nctId":"NCT07341893","phase":"NA","title":"Sacubitril-valsartan in Patients With Heart Failure.","status":"RECRUITING","sponsor":"Damanhour University","startDate":"2025-08-01","conditions":"Heart Failure","enrollment":60},{"nctId":"NCT07334197","phase":"NA","title":"Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy","status":"NOT_YET_RECRUITING","sponsor":"Tanta University","startDate":"2026-12-20","conditions":"Ppm, Cardiomyopathy","enrollment":25},{"nctId":"NCT05931276","phase":"PHASE3","title":"CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2024-05-22","conditions":"End-Stage Kidney Disease, End-Stage Renal Disease","enrollment":2540},{"nctId":"NCT06069102","phase":"PHASE4","title":"Optimal Blood Pressure Treatment Thresholds Postpartum","status":"COMPLETED","sponsor":"Alisse Hauspurg","startDate":"2023-11-15","conditions":"Hypertensive Disorder of Pregnancy, Pre-Eclampsia, Hypertension","enrollment":61},{"nctId":"NCT07313605","phase":"PHASE1, PHASE2","title":"POCUS-Guided Esmolol in Septic Shock: A Pilot RCT","status":"NOT_YET_RECRUITING","sponsor":"John Basmaji","startDate":"2026-01-15","conditions":"Septic Shock","enrollment":100},{"nctId":"NCT07294846","phase":"PHASE1","title":"Drug Interaction Study on Linaprazan Glurate Capsules","status":"COMPLETED","sponsor":"Jiangsu Sinorda Biomedicine Co., Ltd","startDate":"2025-09-08","conditions":"Healthy Volunteers, Patients","enrollment":56},{"nctId":"NCT04682158","phase":"PHASE2","title":"Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma","status":"RECRUITING","sponsor":"Roswell Park Cancer Institute","startDate":"2021-04-01","conditions":"Esophageal Adenocarcinoma","enrollment":106},{"nctId":"NCT06023576","phase":"PHASE2","title":"A Study of Blood Pressure Control During Cancer Treatment","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2023-08-18","conditions":"Breast Cancer, Cardiotoxicity","enrollment":130},{"nctId":"NCT06029712","phase":"PHASE2","title":"Heart Failure Polypill at a Safety Net Hospital","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2024-02-27","conditions":"Heart Failure With Reduced Ejection Fraction, HIV Infections","enrollment":35},{"nctId":"NCT07311109","phase":"NA","title":"A Prospective, Single-center, Randomized Controlled Clinical Study Evaluating the Efficacy and Safety of Hyperbaric Oxygen Therapy as an Adjunctive Treatment for Chronic Heart Failure","status":"NOT_YET_RECRUITING","sponsor":"Fujian Medical University","startDate":"2025-12-15","conditions":"Chronic Heart Failure With Reduced Ejection Fraction","enrollment":150},{"nctId":"NCT04769362","phase":"PHASE4","title":"Long-term Beta-blocker Therapy After Acute Myocardial Infarction","status":"RECRUITING","sponsor":"Samsung Medical Center","startDate":"2021-05-04","conditions":"Myocardial Infarction","enrollment":2540},{"nctId":"NCT07275827","phase":"PHASE3","title":"Comparative Study Evaluating Safety and Effectiveness of ( Proton Pump Inhibitor Versus Vonoprazan ) Based Triple Therapy With or Without Zinc to Eradicate H. Pylori Infection","status":"NOT_YET_RECRUITING","sponsor":"Tanta University","startDate":"2026-02-01","conditions":"HELICOBACTER PYLORI INFECTIONS","enrollment":88},{"nctId":"NCT07285187","phase":"","title":"Venous Congestion And Delirium After Cardiac Surgery","status":"RECRUITING","sponsor":"Zhuan Zhang","startDate":"2024-11-01","conditions":"Intraoperative, Venous Congestion, Postoperative Delirium (POD)","enrollment":120},{"nctId":"NCT05764057","phase":"PHASE3","title":"DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-06-12","conditions":"AMI, STEMI, NSTEMI","enrollment":450},{"nctId":"NCT07295522","phase":"PHASE4","title":"Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap?","status":"NOT_YET_RECRUITING","sponsor":"IRCCS Policlinico S. Donato","startDate":"2026-01-08","conditions":"Heart Failure, Acute Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF)","enrollment":368},{"nctId":"NCT07293832","phase":"","title":"Impact of Cardio-Selective Beta-Blockers on Infarct Size After Acute Myocardial Infarction","status":"RECRUITING","sponsor":"Aristotle University Of Thessaloniki","startDate":"2024-11-13","conditions":"STEMI","enrollment":100},{"nctId":"NCT07074782","phase":"","title":"Retinal Ganglion Cell Neuroprotection Under Prostaglandin Analogues","status":"NOT_YET_RECRUITING","sponsor":"Association for Innovation and Biomedical Research on Light and Image","startDate":"2026-01","conditions":"Glaucoma","enrollment":1500},{"nctId":"NCT07236398","phase":"","title":"Modified Left Atrial Maze Procedure for Concomitant AF Ablation","status":"ENROLLING_BY_INVITATION","sponsor":"University Paul Sabatier of Toulouse","startDate":"2023-06-08","conditions":"Atrial Fibrillation, Cardiac Arrhythmia","enrollment":151},{"nctId":"NCT07262723","phase":"PHASE2, PHASE3","title":"Levosimendan in Acute Decompensated Heart Failure","status":"NOT_YET_RECRUITING","sponsor":"Chittagong Medical College","startDate":"2025-12-01","conditions":"Acute Decompensated Heart Failure (ADHF)","enrollment":332},{"nctId":"NCT05786417","phase":"PHASE4","title":"LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions","status":"RECRUITING","sponsor":"Yale University","startDate":"2023-05-10","conditions":"Angina, Stable Ischemic Heart Disease","enrollment":741},{"nctId":"NCT06183437","phase":"PHASE4","title":"The STOP-MED CTRCD Trial","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2024-03-04","conditions":"Heart Failure, Cardiotoxicity, Cardiac Toxicity","enrollment":335},{"nctId":"NCT05312255","phase":"NA","title":"Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma","status":"RECRUITING","sponsor":"Roswell Park Cancer Institute","startDate":"2022-06-28","conditions":"Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma","enrollment":175},{"nctId":"NCT07238452","phase":"PHASE4","title":"Optimising Pacing Therapy, Integrated Medical Therapy, and Catheter AbLation for Atrial Fibrillation in Heart Failure Trial","status":"NOT_YET_RECRUITING","sponsor":"University of British Columbia","startDate":"2025-12-01","conditions":"Heart Failure With Reduced Ejection Fraction, Atrial Fibrillation (AF)","enrollment":1056},{"nctId":"NCT06472934","phase":"NA","title":"Impact of Beta-blocker on Outcome Among Patients Undergoing Transcatheter Aortic Valve Replacement (B-TAVR)","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2024-07-04","conditions":"Aortic Stenosis","enrollment":498},{"nctId":"NCT04633005","phase":"PHASE2","title":"Polypill Strategy for Heart Failure With Reduced Ejection Fraction","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2021-11-15","conditions":"Heart Failure","enrollment":212},{"nctId":"NCT04713657","phase":"PHASE1","title":"Beta-blocker Administration for Cardiomyocyte Division","status":"RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2022-12-16","conditions":"Tetralogy of Fallot, Double Outlet Right Ventricle","enrollment":40},{"nctId":"NCT05846373","phase":"PHASE2","title":"Effect of Nicotinic Acid as Add on Therapy in Patients Receiving β Blocker for Prophylaxis of Moderate to Severe Migraine","status":"COMPLETED","sponsor":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","startDate":"2022-11-25","conditions":"Migraine Prophylaxis","enrollment":58},{"nctId":"NCT07233421","phase":"NA","title":"Frequency of Hypoglycemia in Children With Beta-blocker Treated Long QT-syndrome","status":"ENROLLING_BY_INVITATION","sponsor":"Helsinki University Central Hospital","startDate":"2024-12-09","conditions":"Long QT Syndrome, Hypoglycemia","enrollment":40},{"nctId":"NCT07232277","phase":"","title":"Venous Congestion and Cardiac Surgery-Associated Acute Kidney Injury","status":"RECRUITING","sponsor":"Zhuan Zhang","startDate":"2024-10-15","conditions":"Intraoperative, Venous Congestion, Cardiac Surgery-associated Acute Kidney Injury","enrollment":114},{"nctId":"NCT07054489","phase":"NA","title":"UPBEAT: Using Polygenic Scores to Guide BB Therapy in HF With Mildly Reduced EF","status":"RECRUITING","sponsor":"David Lanfear","startDate":"2025-11","conditions":"Heart Failure, Polygenic Score","enrollment":10},{"nctId":"NCT05489705","phase":"","title":"A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)","status":"RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2022-08-16","conditions":"Obstructive Hypertrophic Cardiomyopathy","enrollment":1600},{"nctId":"NCT06263452","phase":"PHASE4","title":"Beta-Blocker Influences on Inflammatory and Neural Responses to Stress","status":"RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2024-05-01","conditions":"Cardiovascular Disease","enrollment":120},{"nctId":"NCT05019027","phase":"PHASE4","title":"N-of-1 for Beta-Blockers in Cardiac Amyloidosis","status":"ENROLLING_BY_INVITATION","sponsor":"Weill Medical College of Cornell University","startDate":"2024-01-31","conditions":"Cardiac Amyloidosis, Heart Diseases, TTR Cardiac Amyloidosis","enrollment":20},{"nctId":"NCT06582680","phase":"PHASE4","title":"Aging, Beta Blockers, and Thermoregulatory Responses","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2024-10-04","conditions":"Heat Stress, Aging","enrollment":22},{"nctId":"NCT05585125","phase":"PHASE4","title":"A Preliminary Study for INFORMED","status":"ENROLLING_BY_INVITATION","sponsor":"Weill Medical College of Cornell University","startDate":"2024-02-07","conditions":"Heart Failure, Heart Failure, Diastolic, Heart Failure With Preserved Ejection Fraction","enrollment":20},{"nctId":"NCT05159999","phase":"NA","title":"The Home Blood Pressure (BP) Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Washington","startDate":"2022-02-02","conditions":"End Stage Renal Disease on Dialysis","enrollment":200},{"nctId":"NCT03418961","phase":"PHASE3","title":"S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity","status":"RECRUITING","sponsor":"SWOG Cancer Research Network","startDate":"2017-11-01","conditions":"Cardiotoxicity, HER2/Neu Positive, Metastatic Malignant Neoplasm in the Brain","enrollment":491},{"nctId":"NCT04983823","phase":"NA","title":"Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE)","status":"RECRUITING","sponsor":"Baker Heart and Diabetes Institute","startDate":"2021-11-18","conditions":"Heart Failure","enrollment":820},{"nctId":"NCT05174351","phase":"NA","title":"Beta-blocker Discontinuation in Heart Failure With Preserved Ejection Fraction","status":"RECRUITING","sponsor":"UConn Health","startDate":"2021-12-20","conditions":"Heart Failure With Preserved Ejection Fraction","enrollment":30},{"nctId":"NCT01261065","phase":"PHASE4","title":"Mechanisms of Improvement With Beta-Blocker Treatment in Heart Failure","status":"COMPLETED","sponsor":"Michael E. DeBakey VA Medical Center","startDate":"2001-12","conditions":"Heart Failure, Cardiomyopathy","enrollment":55},{"nctId":"NCT06700213","phase":"","title":"Guideline Directed Medical Therapy in Patients With Heart Failure","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2023-09-22","conditions":"Heart Failure","enrollment":300},{"nctId":"NCT05180773","phase":"PHASE4","title":"Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy","status":"RECRUITING","sponsor":"Dennis M. McNamara, MD, MS","startDate":"2022-07-27","conditions":"Peripartum Cardiomyopathy, Postpartum","enrollment":250},{"nctId":"NCT02479204","phase":"PHASE1","title":"Clinical Study to Investigate Safety and Effects on Heart Rate, Blood Pressure, and Pharmacokinetic Interactions of ACT-334441","status":"TERMINATED","sponsor":"Viatris Innovation GmbH","startDate":"2015-04-28","conditions":"Healthy Subjects","enrollment":10},{"nctId":"NCT07182773","phase":"NA","title":"Pre-infusion Aerobic Cycling Exercise for CardioRespiratory Fitness in Cancer Patients","status":"NOT_YET_RECRUITING","sponsor":"University of Dublin, Trinity College","startDate":"2025-09","conditions":"Cancer","enrollment":80},{"nctId":"NCT05968690","phase":"PHASE1","title":"Naltrexone and Propranolol Combined With Immunotherapy","status":"RECRUITING","sponsor":"Sarah Weiss","startDate":"2023-09-11","conditions":"Advanced Melanoma","enrollment":12},{"nctId":"NCT06964464","phase":"PHASE4","title":"Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator","status":"RECRUITING","sponsor":"University of Rochester","startDate":"2025-08-17","conditions":"Heart Failure With Reduced Ejection Fraction (HFrEF), Sudden Cardiac Death, Ventricular Arrhythmia","enrollment":2000},{"nctId":"NCT07175948","phase":"","title":"Outcome of Clinical Phenotypes of Pediatric Myocarditis at Assiut University Children Hospital","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-06-01","conditions":"Myocarditis, Myocarditis Acute","enrollment":100},{"nctId":"NCT06702436","phase":"","title":"Invasive vs. Conservative Management in Cancer Patients With Non-ST Elevation MI (CAN-NSTEMI)\"","status":"COMPLETED","sponsor":"Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital","startDate":"2024-06-01","conditions":"Myocardial Infarction","enrollment":12500},{"nctId":"NCT04753840","phase":"NA","title":"Long-term of Remote Ischemic Preconditioning in Patients With Mild Hypertension","status":"RECRUITING","sponsor":"Henan Institute of Cardiovascular Epidemiology","startDate":"2021-07-03","conditions":"Hypertension","enrollment":90},{"nctId":"NCT07019818","phase":"PHASE4","title":"Esmolol Versus Sufentanil on the Quality of Post-cholecystectomy Recovery Laparoscopic Anaesthesia With Orotracheal Intubation on an Outpatient Basis","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Limoges","startDate":"2025-11-02","conditions":"Laparoscopic Cholecystectomy Surgery","enrollment":120},{"nctId":"NCT07168421","phase":"PHASE4","title":"LANdiolol to Avoid TAchycardia in Patients at Risk for Cardiovascular Events Undergoing Major Non-cardiac Surgery","status":"NOT_YET_RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2025-10","conditions":"Perioperative Myocardial Injury, Autonomic Dysfunction, Cardiovascular (CV) Risk","enrollment":114},{"nctId":"NCT07168395","phase":"NA","title":"Pre-emptive RTO for An Early Detected Gastric Varices in CT/MR Angiogram Trial","status":"NOT_YET_RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2025-11","conditions":"Gastric Varices","enrollment":68},{"nctId":"NCT06993597","phase":"","title":"Study of Corneal Biomechanics in Glaucoma Patients Using Brillouin Microscopy","status":"RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2025-09-01","conditions":"Glaucoma","enrollment":60},{"nctId":"NCT02472028","phase":"PHASE4","title":"Blood Pressure Reduction to Limit the Evolution of Vascular Brain Lesions in Elderly Individuals","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-09","conditions":"Cerebrovascular Disorders","enrollment":820},{"nctId":"NCT07153744","phase":"PHASE4","title":"Efficacy and Safety of Shexiang Baoxin Pill(MUSKARDIA) in the Treatment of Acute Myocardial Infarction","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Hutchison Pharmaceuticals Limited","startDate":"2025-09-01","conditions":"Acute Myocardial Infarction (AMI), Percutaneous Coronary Intervention (PCI)","enrollment":9588},{"nctId":"NCT06289413","phase":"","title":"Autonomic Dysfunction in Patients Following Bariatric Surgery: The ADiPOSE Study","status":"RECRUITING","sponsor":"Kansas City Heart Rhythm Research Foundation","startDate":"2024-02-12","conditions":"Autonomic Dysfunction, Orthostatic Intolerance","enrollment":400},{"nctId":"NCT04748796","phase":"PHASE3","title":"Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With Hypercontractility","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2021-02-01","conditions":"Septic Shock, Tachycardia, Mortality During Septic Shock","enrollment":360},{"nctId":"NCT06549673","phase":"","title":"Safety of Discontinuing NSBBs in Cirrhotic Patients With Managed Primary Aetiological Factors","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2025-01-20","conditions":"Portal Hypertension, Cirrhosis, Varices, Esophageal","enrollment":375},{"nctId":"NCT07124728","phase":"NA","title":"Syntrillo Telehealth Stroke Risk Reduction Study","status":"NOT_YET_RECRUITING","sponsor":"Syntrillo, Inc","startDate":"2025-08","conditions":"Hypertension, Hypertension (HTN), Stroke Prevention","enrollment":68},{"nctId":"NCT07123506","phase":"NA","title":"Beta-blockers for Prevention of Supraventricular Arrhythmia Following PFO Closure","status":"NOT_YET_RECRUITING","sponsor":"Yonsei University","startDate":"2025-09","conditions":"Atrial Fibrillation, Atrial Flutter, Tachycardia, Supraventricular","enrollment":350},{"nctId":"NCT03504956","phase":"NA","title":"Coronary Atherosclerosis T1-Weighted Characterization (CATCH)","status":"RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2018-07-30","conditions":"Coronary Atherosclerosis","enrollment":150}],"_emaApprovals":[],"_faersSignals":[{"count":152,"reaction":"COMPLETED SUICIDE"},{"count":63,"reaction":"DEATH"},{"count":63,"reaction":"NAUSEA"},{"count":61,"reaction":"DYSPNOEA"},{"count":54,"reaction":"DIZZINESS"},{"count":46,"reaction":"FATIGUE"},{"count":45,"reaction":"DRUG INEFFECTIVE"},{"count":44,"reaction":"HYPOTENSION"},{"count":42,"reaction":"CARDIAC ARREST"},{"count":39,"reaction":"ATRIAL FIBRILLATION"}],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Other medications according to local clinical practice protocols and current guidelines","Timolol","Beta receptor blocker","ABAB","BABA"],"phase":"marketed","status":"active","brandName":"Beta blocker","genericName":"Beta blocker","companyName":"Spanish Society of Cardiology","companyId":"spanish-society-of-cardiology","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Beta blockers reduce heart rate and blood pressure by blocking the effects of adrenaline on beta-adrenergic receptors in the heart and blood vessels. Used for Hypertension, Angina pectoris, Arrhythmias (including atrial fibrillation).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":9,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}